The Takeda deal lets Insilico scale beyond its own pipeline
与武田的这笔交易让公司能够超越自身管线去扩张，成为AI药物发现领域的全球顶级玩家。
English original
the Takeda deal lets the company scale beyond its own pipeline and become a top global player in AI drug discovery
在CNBC关于武田交易的采访中
A
亚历克斯·扎沃龙科夫Insilico Medicine · 创始人
报道摘要
Alex Zhavoronkov, Founder, CEO & CBO of Insilico Medicine, says the Takeda deal lets the company scale beyond its own pipeline and become a top global player in AI drug discovery. He breaks down the ...
CNBC